Skip to main content
SpringerLink
Log in

Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome

An update

  • Review Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Summary

Severe long-term complaints of dumping occur in a small number of patients after gastric surgery. Dietary modification, fiber preparations, and medical therapy are often ineffective. In these severely affected patients administration of the somatostatin analog octreotide before meals appears to be a promising new strategy. The effects of octreotide on both gastrointestinal transit time and hormonal changes appear to contribute to the benefits seen in dumping syndrome. However, as the majority of studies conducted have employed only a single dose of octreotide, careful long-term assessment of the nutritional and metabolic effects will be required. Recent results suggest that octreotide may be administered up to 2 hr before a meal and therefore has a sufficiently long duration of action to be of practical long-term use. Moreover, general improvements in life-style, as well as beneficial effects on symptoms, have been reported with long-term treatment, although the potential development of diarrhea will require careful monitoring. The development of an oral or nasal formulation should further improve the practical application of octreotide as a treatment for dumping syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mix CL: “Dumping stomach” following gastrojejunostomy. Surg Clin North Am 2:617–622, 1922

    Google Scholar 

  2. Woodward ER: The early postprandial dumping syndrome: Clinical manifestations and pathogenesis.In: Postgastrectomy Syndromes. FL Bushkin, ER Woodward (eds). Philadelphia, WB Saunders, 1976, pp 1–13

    Google Scholar 

  3. Woodward ER, Neustein CL: The late postprandial dumping syndrome.In Postgastrectomy Syndromes. FL Bushkin, ER Woodward (eds). Philadelphia: WB Saunders, 1976, pp 28–33

    Google Scholar 

  4. Sawyers JL: Management of postgastrectomy syndromes. Am J Surg 159:8–14, 1990

    Google Scholar 

  5. Primrose JN, Johnston D: Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br J Surg 76:140–144, 1989

    Google Scholar 

  6. Woltering EA, O'Dorisio TM, Williams ST, Lebrado L, Fletcher WS: Treatment of nonendocrine gastrointestinal disorders with octreotide acetate. Metabolism 39:176–179, 1990

    Google Scholar 

  7. Hoffmann J, Jensen H-E, Christiansen J, Olesen A, Loud FB, Hauch O: Prospective controlled vagotomy trial for duodenal ulcer. Ann Surg 209:40–45, 1989

    Google Scholar 

  8. Johnston D, Blackett RL: A new look at the selective vagotomies. Am J Surg 156:412–428, 1988

    Google Scholar 

  9. Tytgat GNJ, Offerhaus GJA, Mulder CJJ, van der Berg BT: Consequences of gastric surgery for benign conditions: an overview. Hepato-Gastroenterol 35:271–278, 1988

    Google Scholar 

  10. Kneepkens CMF, Fernandes J, Vonk RJ: Dumping syndrome in children. Acta Paediatr Scand 77:279–286, 1988

    Google Scholar 

  11. Ralphs DNL, Thomson JPS, Haynes S, Lawson-Smith C, Hobsley M, Le Quesne LP: The relationship between the rate of gastric emptying and the dumping syndrome. Br J Surg 65:637–641, 1978

    Google Scholar 

  12. Fenger HJ: The dumping disposition in normal persons. Acta Chir Scand 129:201–210, 1965

    Google Scholar 

  13. Lawaetz O, Blackburn AM, Bloom SR, Aritas Y, Ralphs DNL: Gut hormone profile and gastric emptying in the dumping syndrome. Scand J Gastroenterol 18:73–80, 1983

    Google Scholar 

  14. Sagor GR, Bryant MG, Ghatei MA, et al: Release of vasoactive intestinal peptide in the dumping syndrome. Br Med J 282:507–510, 1981

    Google Scholar 

  15. Blackburn AM, Christofides ND, Ghatei MA, et al: Elevation of plasma neurotensin in the dumping syndrome. Clin Sci 59:237–243, 1980

    Google Scholar 

  16. Jenkins DJA, Glassell MA, Leeds AR: Effect of dietary fiber on complications of gastric surgery: Prevention of postprandial hypoglycemia by pectin. Gastroenterology 72:215–217, 1977

    Google Scholar 

  17. Hopman WPM, Houben PGMP, Speth PAJ, Lamers CBHW: Glucomannan prevents postprandial hypoglycaemia in patients with previous gastrectomy. Gut 29:930–934, 1988

    Google Scholar 

  18. Speth PAJ, Jansen JBMJ, Lamers CBHW: Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. Gut 24:789–802, 1983

    Google Scholar 

  19. Brogard JM, Willemin B, Blické JF, Lamalle AM, Stahl A: Inhibiteurs des alpha-glucosidases: une nouvelle approche thérapeutique du diabète et des hypoglycémies fonctionelles. Rev Med Interne 10:365–374, 1989

    Google Scholar 

  20. Krulich L, Dhariwal APS, McCann SM: Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitaryin vitro. Endocrinology 83:783–790, 1968

    Google Scholar 

  21. Brazeu P, Vale W, Burgus R, et al: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 173:77–79, 1973

    Google Scholar 

  22. Reichlin S: Somatostatin. N Engl J Med 309:1495–1501, 1556–1563, 1983

    Google Scholar 

  23. Johansson C, Wisen O, Efendic S, et al: Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22:126–137, 1981

    Google Scholar 

  24. Long RG, Adrian TE, Bloom SR: Somatostatin and the dumping syndrome. Br Med J 290:886–888, 1985

    Google Scholar 

  25. Reasbeck PG, Van Rij AM: The effect of somatostatin on dumping after gastric surgery. A preliminary report. Surgery 99:442–468, 1986

    Google Scholar 

  26. Tulassay Z, Tulassay T, Tamas G Jr: Benefit of somatostatin in dumping syndrome. Surgery 103:130–131, 1988

    Google Scholar 

  27. Bauer W, Briner U, Doepfner W, et al: SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133–1140, 1982

    Google Scholar 

  28. O'Donnell LJD, Farthing MJG: Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases. Gut 30:1165–1172, 1989

    Google Scholar 

  29. Schluter KJ, Marbach P, del Pozo E, Kerp L: Receptor binding of a new modified potent and selective somatostatin (SMS 201-995). Diabetes 32(suppl 1):135A, 1983

    Google Scholar 

  30. Primrose JN: Octreotide in the treatment of the dumping syndrome. Digestion 45(suppl 1):49–59, 1990

    Google Scholar 

  31. Santangelo WC, Dueno MI, Pike I, et al: Clinical efficacy of the somatostatin analogue 201-995 in the post-gastrectomy dumping syndrome. Gastroenterology 92:1613, 1987

    Google Scholar 

  32. Primrose JN, Johnston D: Somatostatin analogue SMS 201-995 is an effective treatment for the post gastric surgery-dumping syndrome provoked by hypertonic glucose. Gastroenterology 91:1580, 1987

    Google Scholar 

  33. Geoghegan JG, Meyers MC, Pappas TN: Octreotide: Clinical experience in 62 patients with gastrointestinal disease. Gastroenterology 98:A47, 1990

    Google Scholar 

  34. Parr N, Grime S, Jenkins SA, Critchley M, Baxter J, Mackie C: Somatostatin analogue (SMS 201-995) inhibits early rapid emptying after truncal vagotomy and drainage. Gut 27:A1272-A1273, 1986

    Google Scholar 

  35. Kapoor A, Miglietta J, Berelowitz M: Use of long-acting somatostatin analog (Sandostatin, SMS 201-995) in the treatment of refractory postgastrectomy hypoglycemia. Clin Res 35:507A, 1987

    Google Scholar 

  36. Primrose JN, Bramley P, Johnston D: The use of octreotide (SMS 201-995) in the treatment of intractable dumping after vagotomy or gastrectomy. Gastroenterology 94:A360, 1988

    Google Scholar 

  37. D'Cruz DP, Reynard J, Tatman AJ, Kopelman PG: Longterm symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue. Postgrad Med J 65:116–117, 1989

    Google Scholar 

  38. Thirlby RC: Somatostatin and post-gastrectomy dumping. Gastroenterology 97:1344, 1989

    Google Scholar 

  39. Hopman WPM, Wolberink RGJ, Lamers CBHW, Van Tongeren JHM: Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 207:155–159, 1988

    Google Scholar 

  40. Ouyang A: Somatostatin analogue in the treatment of dumping syndrome: A new treatment for an old problem. Comment on selected summary of ref. 39. Gastroenterology 95:1684–1685, 1988

    Google Scholar 

  41. Tulassay Z, Tulassay T, Gupta R, Cierny G: Long acting somatostatin analogue in dumping syndrome. Br J Surg 76:1294–1295, 1989

    Google Scholar 

  42. Tulassay Z, Tulassay T, Gupta R, Cierny G: Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 210:250–252, 1989

    Google Scholar 

  43. Geer R, Richard WO, O'Dorisio TM: Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 212:678–687, 1990

    Google Scholar 

  44. Richards WO, Geer R, O'Dorisio TM, et al: Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res 49:483–487, 1990

    Google Scholar 

  45. Masclee AAM, Jansen JBMJ, Lamers CBHW: Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders. Neth J Med 39:356–365, 1991

    Google Scholar 

  46. van Liessum PA, Hopman WPM, Pieters GFFM, et al: Postprandial gallbladder motility during longterm treatment with the long acting somatostatin analog SMS 201-995 in acromegaly. J Clin Endocrinol Metab 69:557–562, 1989

    Google Scholar 

  47. Cucchiaro G, Branum GD, O'Dorisio T, Meyers WC: Effect of somatostatin and its analogue sandostatin on biliary lipid. Gastroenterology 98:A246, 1990

    Google Scholar 

  48. Barkan Al, Kelch RP, Hopwood NJ, Beitins IZ: Treatment of acromegaly with the long acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab 66:16–23, 1988

    Google Scholar 

  49. Tauber JP, Babin TH, Tauber MT et al: Long-term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. J Clin Endocrinol Metab 68:917–924, 1989

    Google Scholar 

  50. Fletcher DM, Clark CG: Gallstones and gastric surgery. Br J Surg 55:895–899, 1968

    Google Scholar 

  51. Williams G, Burrin JM, Ball JA, Joplin GF, Bloom SR: Effective and lasting growth-hormone suppression in active acromegaly with oral administration of somatostatin analogue SMS 201-995. Lancet 2:774–778, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, University Hospital Leiden, The Netherlands

    Cornelis B. H. W. Lamers MD, Anne M. Bijlstra MD & Alan G. Harris MD

  2. Sandoz Pharma AG, Basel, Switzerland

    Cornelis B. H. W. Lamers MD, Anne M. Bijlstra MD & Alan G. Harris MD

  3. Division of Clinical Pharmacology, Cedars-Sinai Medical Center, Los Angeles, California

    Cornelis B. H. W. Lamers MD, Anne M. Bijlstra MD & Alan G. Harris MD

Authors
  1. Cornelis B. H. W. Lamers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne M. Bijlstra MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan G. Harris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lamers, C.B.H.W., Bijlstra, A.M. & Harris, A.G. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. Digest Dis Sci 38, 359–364 (1993). https://doi.org/10.1007/BF01307556

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01307556

Key Words

Search

Navigation